Prognostic significance of progesterone receptor levels in luminal-like Her2-early breast cancer patients. A retrospective single cancer center analysis

被引：0
|
作者：
Diana, A. [1 ]
Carlino, F. [1 ]
Franzese, E. [1 ]
Centonze, S. [1 ]
Guerrera, L. P. [1 ]
Perrone, A. [1 ]
De Vita, F. [1 ]
Ciardiello, F. [1 ]
Orditura, M. [1 ]
机构：
[1] Univ Campania Luigi Vanvitelli, Dept Precis Med, Naples, Italy
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
247P
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Prognostic Role of p53 Immunohistochemical Status in invasive Breast Cancer. A Retrospective Review of 1387 Cases With Luminal-Like/Her2 Negative Breast Tumors
    Dajti, Gerti
    Serra, Margherita
    Cisternino, Giovanni
    Ceccarelli, Claudio
    Pellegrini, Alice
    Melina, Marica
    De Leo, Antonio
    Santini, Donatella
    Taffurelli, Mario
    Zanotti, Simone
    ONCOLOGIST, 2023, : 384 - 391
  • [22] Progesterone receptor status and Ki-67 index provide prognostic value for early relapse in luminal B/HER2 negative breast cancer patients
    Zong, Y.
    Zhu, L.
    Wu, J.
    Chen, X.
    Huang, O.
    Fei, X.
    He, J.
    Chen, W.
    Li, Y.
    Shen, K.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S445 - S445
  • [23] The prognostic significance of PELP1 expression in invasive breast cancer with emphasis on the ER-positive luminal-like subtype
    Hany Onsy Habashy
    Desmond G. Powe
    Emad A. Rakha
    Graham Ball
    R. Douglas Macmillan
    Andrew R. Green
    Ian O. Ellis
    Breast Cancer Research and Treatment, 2010, 120 : 603 - 612
  • [24] The prognostic significance of PELP1 expression in invasive breast cancer with emphasis on the ER-positive luminal-like subtype
    Habashy, Hany Onsy
    Powe, Desmond G.
    Rakha, Emad A.
    Ball, Graham
    Macmillan, R. Douglas
    Green, Andrew R.
    Ellis, Ian O.
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 120 (03) : 603 - 612
  • [25] Prognostic value of serum HER-2 in early stage breast cancer (BC) patients.
    Gori, S.
    Ludovini, V
    Mosconi, A.
    Pistola, L.
    Rulli, E.
    Rulli, A.
    Anastasi, P.
    Basurto, C.
    Sidoni, A.
    Tofanetti, F. R.
    Colozza, M.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S92 - S92
  • [26] Prognostic and biological significance of proliferation and HER2 expression in the luminal class of breast cancer
    Dena A. Jerjees
    M. Alabdullah
    Andrew R. Green
    Alaa Alshareeda
    R. D. Macmillan
    Ian O. Ellis
    Emad A. Rakha
    Breast Cancer Research and Treatment, 2014, 145 : 317 - 330
  • [27] Prognostic and biological significance of proliferation and HER2 expression in the luminal class of breast cancer
    Jerjees, Dena A.
    Alabdullah, M.
    Green, Andrew R.
    Alshareeda, Alaa
    Macmillan, R. D.
    Ellis, Ian O.
    Rakha, Emad A.
    BREAST CANCER RESEARCH AND TREATMENT, 2014, 145 (02) : 317 - 330
  • [28] Prognostic Significance of Progesterone Receptor-Positive Tumor Cells Within Immunohistochemically Defined Luminal A Breast Cancer
    Prat, Aleix
    Cheang, Maggie Chon U.
    Martin, Miguel
    Parker, Joel S.
    Carrasco, Eva
    Caballero, Rosalia
    Tyldesley, Scott
    Gelmon, Karen
    Bernard, Philip S.
    Nielsen, Torsten O.
    Perou, Charles M.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (02) : 203 - 209
  • [29] Prognostic significance of HLA-A2 status in breast cancer patients.
    Dehqanzada, Z
    Hueman, MT
    Shriver, CD
    Ponniah, S
    Peoples, GE
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 886S - 886S
  • [30] Progesterone Receptor Status and Ki-67 Index May Predict Early Relapse in Luminal B/HER2 Negative Breast Cancer Patients: A Retrospective Study
    Zong, Yu
    Zhu, Li
    Wu, Jiayi
    Chen, Xiaosong
    Huang, Ou
    Fei, Xiaochun
    He, Jianrong
    Chen, Weiguo
    Li, Yafen
    Shen, Kunwei
    PLOS ONE, 2014, 9 (08):
12345